Coloplast A/S

    Jurisdiction
    Denmark
    LEI
    529900NN7SOJ5QG82X67
    ISIN
    DK0060448595 (COLO-B.CO)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    52 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €69.27 9.8% overvalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €3.73B
    Gross margin
    67.5%
    EBIT
    €1.01B
    EBIT margin
    27.1%
    Net income
    €545.92M
    Net margin
    14.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €3.95B +5.8% €772.31M +41.5%
    €4.24B +7.4% €854.03M +10.6%
    €4.63B +9.1% N/A

    Dividends

    Last dividend amount
    DKK 5.00
    Ex date
    Payment date
    Dividend payout ratio
    121.7%

    Earnings Calls

    Latest earnings call: August 19, 2025

    Add to watchlist

    Notifications